VaLea Clinical Trials
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
Early data from a clinical trial in France has demonstrated encouraging profile of Roche unit Genentech’s rheumatoid arthritis drug tocilizumab (Actemra) to treat seriously ill Covid-19 patients.
The study, which was conducted by the Paris university hospital trust (AP-HP), involved 129 hospitalised patients with moderate or severe viral pneumonia.
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
SaaS Platform Decentralizing Clinical Research at Scale
Cloud-Based Off-the-Shelf Clinical Metadata Repository and Clinical Trial Automation Software Platform